(Q32122293)

6 July 2017

1 reference

title

Assessment of suspected dementia (English)

1 reference

6 July 2017

1 reference

Chertkow H

1

1 reference

6 July 2017

Bergman H

2

1 reference

6 July 2017

Schipper HM

3

1 reference

6 July 2017

Gauthier S

4

1 reference

6 July 2017

Bouchard R

5

1 reference

6 July 2017

Fontaine S

6

1 reference

6 July 2017

Clarfield AM

7

1 reference

6 July 2017

publication date

1 February 2001

1 reference

Canadian Journal of Neurological Sciences

6 July 2017

published in

1 reference

6 July 2017

volume

28 Suppl 1

1 reference

6 July 2017

page(s)

S28-41

1 reference

Diagnostic markers for Alzheimer's disease.

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

HM-PAO (CERETEC) SPECT brain scanning in the diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Preclinical prediction of Alzheimer's disease using SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

The diagnosis of dementia with single photon emission computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

CSF tau and Abeta42: logical biomarkers for Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Management of neurological disorders: dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

The medial temporal lobe in dementia with Lewy bodies: a comparative study with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

A study of language functioning in Alzheimer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Dementia as the most common presentation of cortical-basal ganglionic degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Different patterns of cognitive decline related to normal or deteriorating EEG in a 3-year follow-up study of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Evaluation of dementia: a systematic study of the usefulness of the American Academy of Neurology's practice parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Cognitive deficits and clinical diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

A 7 minute neurocognitive screening battery highly sensitive to Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Corticobasal degeneration: neuropathologic and clinical heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Diagnostic criteria for sporadic Creutzfeldt-Jakob disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

The Clock Test: a sensitive measure to differentiate normal elderly from those with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Screening for dementia by memory testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Mini-mental state examination in neurological patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

The Mini-Mental State Examination: A Comprehensive Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Screening for dementia and investigating its causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Extrapyramidal signs in patients with probable Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Clinical and quantitative pathologic correlates of dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Diagnosis of dementia: Clinicopathologic correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Pathological verification of ischemic score in differentiation of dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Cerebral blood flow in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Specific cognitive deficits in mild frontal variant frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Differentiating frontal and temporal variant frontotemporal dementia from Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Inheritance of frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Neurologic signs in senescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Cognition-independent neurologic symptoms in normal aging and probable Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Neurological findings in Alzheimer's disease and normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

The neurologic examination in patients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Depression, cognition, and functional ability in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

The presence of leuko-araiosis in patients with Alzheimer's disease predicts poor tolerance to tacrine, but does not discriminate responders from non-responders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Cortical Lewy body dementia: clinical features and classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Non Alzheimer's disease forms of cerebral atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Neuropsychological syndromes in presenile dementia due to cerebral atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Focal cortical atrophy syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Dementias that present with and without posterior cortical features: an important clinical distinction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

21 January 2018

Evaluation of dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Reversible dementia: more than 10% or less than 1%? A quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

A population-based study of dementia in 85-year-olds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

The American and Canadian consensus conferences on dementia: is there consensus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

The reversible dementias: do they reverse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

The effect of different diagnostic criteria on the prevalence of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Prevalence and severity of cognitive impairment with and without dementia in an elderly population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

The validity of new memory complaints in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Do cognitive complaints either predict future cognitive decline or reflect past cognitive decline? A longitudinal study of an elderly community sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Screening for early dementia using memory complaints from patients and relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

The prediction of Alzheimer disease. The role of patient and informant perceptions of cognitive deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Mild cognitive impairment: conceptual basis and current nosological status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

A Follow‐Up Study of Age‐Associated Memory Impairment: Neuropsychological Predictors of Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Predicting conversion to Alzheimer disease using standardized clinical information.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

A typology of sub-clinical senescent cognitive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

A new clinical scale for the staging of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

Diagnosis and evaluation of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

Physicians' assessment of cognitive capacity. Failure to meet the needs of the elderly

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

Diagnosis of vascular dementia: Consortium of Canadian Centres for Clinical Cognitive Research concensus statement.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

Reversible dementia in elderly patients referred to a memory clinic

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

Aging-Associated Cognitive Decline

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

Overdiagnosis of Dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

A New Systematic Method of Measurement and Diagnosis of “Mild Cognitive Impairment” and Dementia According to ICD-10 and DSM-III-R Criteria

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

Severe depressive pseudodementia with and without dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

The pathology and nosology of primary progressive aphasia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

Physostigmine and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

Validity of clinical criteria for the diagnosis of dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

Early diagnosis of dementia via a two-step screening and diagnostic procedure.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

Olfactory identification deficits in relatives of Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

Heterogeneity in dementia of the Alzheimer type: evidence of subgroups

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

Predicting who will develop dementia in a cohort of Canadian seniors.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

Differential diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

The role of lumbar puncture in the evaluation of dementia: the University of Pittsburgh Study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

Alzheimer's disease: clinical implications of the apolipoprotein E genotype

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

Neurological abnormalities associated with severity of dementia in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

Coexistence of cognitive impairment and depression in geriatric outpatients

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

The validity of the diagnosis of mild dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

Diagnostic challenges in dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

The usefulness of CT scanning in diagnosing dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001189

7 January 2021

10.1017/S0317167100001189

Identifiers

DOI

1 reference

6 July 2017

1 reference